Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 700

1.

Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.

Sanchez-Ramos J, Song S, Sava V, Catlow B, Lin X, Mori T, Cao C, Arendash GW.

Neuroscience. 2009 Sep 29;163(1):55-72. doi: 10.1016/j.neuroscience.2009.05.071. Epub 2009 Jun 14.

PMID:
19500657
2.

Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures.

Lue LF, Walker DG, Rogers J.

Neurobiol Aging. 2001 Nov-Dec;22(6):945-56. Review.

PMID:
11755003
3.

Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.

Halliday G, Robinson SR, Shepherd C, Kril J.

Clin Exp Pharmacol Physiol. 2000 Jan-Feb;27(1-2):1-8. Review.

PMID:
10696521
4.

Mouse models of Alzheimer's disease: insight into treatment.

German DC, Eisch AJ.

Rev Neurosci. 2004;15(5):353-69. Review.

PMID:
15575491
5.

NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus.

Yamin G.

J Neurosci Res. 2009 Jun;87(8):1729-36. doi: 10.1002/jnr.21998. Review.

PMID:
19170166
6.

Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.

El Khoury J, Luster AD.

Trends Pharmacol Sci. 2008 Dec;29(12):626-32. doi: 10.1016/j.tips.2008.08.004. Epub 2008 Oct 1. Review.

PMID:
18835047
7.

The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications.

Rozemuller AJ, van Gool WA, Eikelenboom P.

Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):223-33. Review.

PMID:
15975026
8.

Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.

Jack CR Jr, Marjanska M, Wengenack TM, Reyes DA, Curran GL, Lin J, Preboske GM, Poduslo JF, Garwood M.

Neuroscientist. 2007 Feb;13(1):38-48. Review.

PMID:
17229974
9.

Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease.

Simard AR, Rivest S.

Mol Psychiatry. 2006 Apr;11(4):327-35. Review.

PMID:
16491130
10.

Microglial activation in Alzheimer's disease.

Schlachetzki JC, Hüll M.

Curr Alzheimer Res. 2009 Dec;6(6):554-63. Review.

PMID:
19747160
11.

Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease.

Harkany T, Hortobágyi T, Sasvári M, Kónya C, Penke B, Luiten PG, Nyakas C.

Prog Neuropsychopharmacol Biol Psychiatry. 1999 Aug;23(6):963-1008. Review.

PMID:
10621945
12.

Caffeine and coffee as therapeutics against Alzheimer's disease.

Arendash GW, Cao C.

J Alzheimers Dis. 2010;20 Suppl 1:S117-26. doi: 10.3233/JAD-2010-091249. Review.

PMID:
20182037
13.

Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease.

Standridge JB.

Curr Alzheimer Res. 2006 Apr;3(2):95-108. Review.

PMID:
16611010
14.

[Therapy of Alzheimer disease].

Kovács T.

Neuropsychopharmacol Hung. 2009 Mar;11(1):27-33. Review. Hungarian.

15.

Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics.

Morgan D, Gordon MN, Tan J, Wilcock D, Rojiani AM.

J Neuropathol Exp Neurol. 2005 Sep;64(9):743-53. Review.

PMID:
16141783
16.

Clinical aspects of inflammation in Alzheimer's disease.

Rosenberg PB.

Int Rev Psychiatry. 2005 Dec;17(6):503-14. Review.

PMID:
16401549
17.

Microglial activation and its implications in the brain diseases.

Dheen ST, Kaur C, Ling EA.

Curr Med Chem. 2007;14(11):1189-97. Review.

PMID:
17504139
18.

Adult neurogenesis: a potential tool for early diagnosis in Alzheimer's disease?

Lopez-Toledano MA, Ali Faghihi M, Patel NS, Wahlestedt C.

J Alzheimers Dis. 2010;20(2):395-408. doi: 10.3233/JAD-2010-1388. Review.

PMID:
20164555
19.

Metal and inflammatory targets for Alzheimer's disease.

Rogers JT, Lahiri DK.

Curr Drug Targets. 2004 Aug;5(6):535-51. Review.

PMID:
15270200
20.

[The lesions of Alzheimer's disease: which therapeutic perspectives?].

Duyckaerts C, Perruchini C, Lebouvier T, Potier MC.

Bull Acad Natl Med. 2008 Feb;192(2):303-18; discussion 318-21. Review. French.

PMID:
18819685

Supplemental Content

Support Center